Search Results

Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learned

Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learned

CAR T Cell Therapy in Hematologic Malignancies

CAR T Cell Therapy in Hematologic Malignancies

Engineering T cells: moving beyond leukemia

Engineering T cells: moving beyond leukemia

Immunomodulation of NK cells for the treatment of lymphoid malignancies

Immunomodulation of NK cells for the treatment of lymphoid malignancies

T Cell Engager Antibodies – focus on Hematological Malignancies | Presented by Dr. John Kuruvilla

T Cell Engager Antibodies – focus on Hematological Malignancies | Presented by Dr. John Kuruvilla

FT596: iPSC-derived CAR-NK cells with engineered persistence for B-cell malignancies

FT596: iPSC-derived CAR-NK cells with engineered persistence for B-cell malignancies

All you need for immuno-oncology B cell research [WEBINAR]

All you need for immuno-oncology B cell research [WEBINAR]

Adaptimmune's Symposium at CTOS 2021– “Spotlight on Synovial Sarcoma; Where are we now? Where next?”

Adaptimmune's Symposium at CTOS 2021– “Spotlight on Synovial Sarcoma; Where are we now? Where next?”

ACTRIS Cell Therapy Lecture Series : Role of Current Stem Cell Therapy for Malignant Haematology

ACTRIS Cell Therapy Lecture Series : Role of Current Stem Cell Therapy for Malignant Haematology

$Relapsed/Refractory B-cell Lymphomas in the CAR-T Era: Improving Outcomes in a Population at Need$

Relapsed/Refractory B-cell Lymphomas in the CAR-T Era: Improving Outcomes in a Population at Need

Emerging Immunotherapies for the Treatment of B Cell Malignancies

Emerging Immunotherapies for the Treatment of B Cell Malignancies

How Does Immunotherapy Combat Cancer? Let’s get to know the latest CAR-T Cell Therapy (full version)

How Does Immunotherapy Combat Cancer? Let’s get to know the latest CAR-T Cell Therapy (full version)